KSC:033270
Korea United Pharm Inc. · KSC · Healthcare · KRW · FY for 2025
Figures on this page computed 2026-11-07 22:40 UTC
Last close
n/aKRW
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
6.0xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
- Computed from the filing for 2025
8.8%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
13.3%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
9.6%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.03Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
2.6%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
Growth is the furthest below its sector's middle: 0.47 against 0.47 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.22x
Its own average over 10 years, 236.31B.
- Profit1.16x
Its own average over 10 years, 32.95B.
- Free cash flow1.37x
Its own average over 10 years, 20.26B.
- Debt0.51x
Its own average over 10 years, 27.68B.
- Pricen/a
Its own average over 0 years. Market data
Debt is furthest from its own average, at 0.51 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 111.4 | 142.8 | 96.9 |
| 2018-12-31 | 119.8 | 162.3 | 96.9 |
| 2019-12-31 | 125.1 | 158.4 | 97.0 |
| 2020-12-31 | 122.1 | 136.4 | 97.5 |
| 2021-12-31 | 124.9 | 146.8 | 97.8 |
| 2022-12-31 | 148.4 | 232.0 | 97.5 |
| 2023-12-31 | 157.7 | 247.3 | 96.4 |
| 2024-12-31 | 163.2 | 166.3 | 96.4 |
| 2025-12-31 | 163.2 | 196.3 | 106.9 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Figures behind the shape
Growth
6.0%faster is higher, placed against 4,950 companies as of 2026-11-06
Five-year revenue growth rate6.0%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
Five-year EPS growth rate7.8%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
One-year change in net income18.0%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
Returns on capital
8.8%higher is higher, placed against 5,089 companies as of 2026-11-06
Return on invested capital8.8%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity8.4%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets7.4%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
60.7%wider is higher, placed against 3,412 companies as of 2026-11-06
Gross margin60.7%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin16.9%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin13.3%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin9.6%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
6.0xcheaper is higher, placed against 4,362 companies as of 2026-11-06
Price to earnings6.0x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
- Computed from the filing for 2025
Price to book0.6x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA3.8x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio0.9x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
0.03safer is higher, placed against 3,227 companies as of 2026-11-06
Debt to equity0.03
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio5.63
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage281.8x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score4.89
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
2.6%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-06
Dividend yield2.6%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
Payout ratio17.3%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio4.2x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- KRW
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.